Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 741.91

-1.6%

Jan 15 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: harkenman who wrote (58)	3/24/1997 1:13:00 PM
From: James Silverman	of 3559

Hark, P&G can throw $10M at REGN it doesnt mean a thing to them. Its a pittance. What does P&G know about drug development? They are a marketing machine not a drug developer. Their deal is so far off, I place little to no value in it. And I agree with the other poster, an AMGN buyout of REGN makes a lot of sense for AMGN. They have sunk $10's of millions in REGN, have several programs with them, own over 20% of the stock already and could pay next to nothing for them. Factor in the REGN cash and tax losses and what would they effectively be paying at current prices? Caveat: I own shares in REGN.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next